Publicaciones en las que colabora con Carla Rios Luci (27)

2020

  1. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells

    Investigational New Drugs, Vol. 38, Núm. 3, pp. 584-598

2018

  1. A Small Molecule Tubulin Depolymerizing Agent Identified by a Phenotypic Drug Discovery Approach

    Journal of Molecular and Clinical Medicine, Vol. 1, Núm. 2, pp. 67-76

2017

  1. DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells

    European Journal of Pharmaceutical Sciences, Vol. 105, pp. 159-168

2014

  1. Antiproliferative and quinone reductase-inducing activities of withanolides derivatives

    European Journal of Medicinal Chemistry, Vol. 82, pp. 68-81

  2. QSAR on antiproliferative naphthoquinones based on a conformation- independent approach

    European Journal of Medicinal Chemistry, Vol. 77, pp. 176-184

2013

  1. Expanding the synthesis of new trans-sulfonamide platinum complexes: Cytotoxicity, SAR, fluorescent cell assays and stability studies

    Journal of Inorganic Biochemistry, Vol. 127, pp. 128-140

  2. Molecular docking studies of the interaction between propargylic enol ethers and human DNA topoisomerase IIα

    Bioorganic and Medicinal Chemistry Letters, Vol. 23, Núm. 19, pp. 5382-5384

  3. Novel clioquinol and its analogous platinum complexes: Importance, role of the halogen substitution and the hydroxyl group of the ligand

    Dalton Transactions, Vol. 42, Núm. 37, pp. 13343-13348

2012

  1. Anti-Inflammatory Activity of a Novel Family of Aryl Ureas Compounds in an Endotoxin-Induced Airway Epithelial Cell Injury Model

    PLoS ONE, Vol. 7, Núm. 11

  2. Antiproliferative activity of withanolide derivatives from Jaborosa cabrerae and Jaborosa reflexa. Chemotaxonomic considerations

    Phytochemistry, Vol. 76, pp. 150-157

  3. Cytotoxic bioactivity of some phenylpropanoic acid derivatives

    Natural Product Communications, Vol. 7, Núm. 10, pp. 1341-1346

  4. Heterometallic platinum(ii) compounds with β-aminoethylferrocenes: Synthesis, electrochemical behaviour and anticancer activity

    Dalton Transactions, Vol. 41, Núm. 2, pp. 432-441

  5. In vitro synergistic interaction between DTA0100 and radiation in human cancercell lines

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 12, Núm. 8, pp. 988-993

  6. Phenotypic drug discovery. Identification of the mechanism of action of antiproliferative compounds

    Phenotypic drug discovery. Identification of the mechanism of action of antiproliferative compounds

  7. Reactivity and biological properties of a series of cytotoxic PtI 2(amine) 2 complexes, either cis or trans configured

    Inorganic Chemistry, Vol. 51, Núm. 3, pp. 1717-1726

  8. β-Lapachone analogs with enhanced antiproliferative activity

    European Journal of Medicinal Chemistry, Vol. 53, pp. 264-274

2011

  1. A modular approach to trim cellular targets in anticancer drug discovery

    Bioorganic and Medicinal Chemistry Letters, Vol. 21, Núm. 22, pp. 6641-6645

  2. Antiproliferative activity of dmoPTA-Ru(II) complexes against human solid tumor cells

    Bioorganic and Medicinal Chemistry Letters, Vol. 21, Núm. 15, pp. 4568-4571

  3. Novel N-sulfonamide trans-platinum complexes: Synthesis, reactivity and in vitro evaluation

    MedChemComm, Vol. 2, Núm. 8, pp. 789-793

  4. Synthesis and Biological Evaluation of 1-Deoxy-5-hydroxysphingosine Derivatives

    European Journal of Organic Chemistry, pp. 960-967